Friday, July 10, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “formoterol” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 17
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 17 pipeline programs matching "formoterol" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

17 results for “formoterol” Back to intelligence hub

Search results

  1. Aclidinium bromide/formoterol Fixed-Dose Combination

    AstraZeneca

    COPD

    phase 3 small molecule completed

    1 trial
  2. Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)

    AstraZeneca

    Chronic Obstructive Pulmonary Disease

    phase 3 small molecule completed

    1 trial
  3. Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial
  4. Budesonide/Formoterol SPIROMAX®

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial
  5. Budesonide/Formoterol fumarate dihydrate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule active

    1 trial
  6. Budesonide/formoterol Turbuhaler

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial
  7. Fluticasone/ Formoterol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Asthma

    phase 3 small molecule active

    1 trial
  8. Generic Budesonide/Formoterol Fumarate Dihydrate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial
  9. budesonide/formoterol 'as needed' + budesonide placebo bid

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial
  10. formoterol

    Pacira Ireland Limited

    Asthma

    phase 3 other completed

    1 trial
  11. Formoterol

    Pacira Ireland Limited

    Chronic Obstructive Pulmonary Disease

    approved small molecule completed

    1 trial
  12. Salmeterol/fluticasone propionate or formoterol/budesonide

    GlaxoSmithKline

    Asthma

    approved small molecule completed

    1 trial
  13. Symbicort Turbuhaler (budesonide/formoterol) 320/9 μg

    AstraZeneca

    Chronic Obstructive Pulmonary Disease (COPD)

    approved small molecule completed

    1 trial
  14. budesonide/formoterol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cough Variant Asthma

    approved small molecule active

    1 trial
  15. formoterol fumarate

    Universal Integrated

    Pulmonary Disease, Chronic Obstructive

    approved small molecule completed

    1 trial
  16. Budesonide/formoterol

    The First People's Hospital of Lianyungang

    COPD Exacerbation

    small molecule completed

    1 trial
  17. formoterol

    Teva Pharma GmbH

    Asthma

    small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.